The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
Global Latent Tuberculosis Infection Screening Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Latent Tuberculosis Infection Screening Test market research.
Key companies engaged in the Latent Tuberculosis Infection Screening Test industry include Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi and Par Sterile, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Latent Tuberculosis Infection Screening Test were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Latent Tuberculosis Infection Screening Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Latent Tuberculosis Infection Screening Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Qiagen
- Oxford Immunotec
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Sanofi
- Par Sterile
Segment by Type
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
Segment by Application
- Hospital
- Diagnostic Laboratories
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Latent Tuberculosis Infection Screening Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection Screening Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection Screening Test Market Perspective (2018-2029)
2.2 Latent Tuberculosis Infection Screening Test Growth Trends by Region
2.2.1 Global Latent Tuberculosis Infection Screening Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Latent Tuberculosis Infection Screening Test Historic Market Size by Region (2018-2023)
2.2.3 Latent Tuberculosis Infection Screening Test Forecasted Market Size by Region (2024-2029)
2.3 Latent Tuberculosis Infection Screening Test Market Dynamics
2.3.1 Latent Tuberculosis Infection Screening Test Industry Trends
2.3.2 Latent Tuberculosis Infection Screening Test Market Drivers
2.3.3 Latent Tuberculosis Infection Screening Test Market Challenges
2.3.4 Latent Tuberculosis Infection Screening Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection Screening Test Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection Screening Test Players by Revenue (2018-2023)
3.1.2 Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Players (2018-2023)
3.2 Global Latent Tuberculosis Infection Screening Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent Tuberculosis Infection Screening Test Revenue
3.4 Global Latent Tuberculosis Infection Screening Test Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection Screening Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection Screening Test Revenue in 2022
3.5 Latent Tuberculosis Infection Screening Test Key Players Head office and Area Served
3.6 Key Players Latent Tuberculosis Infection Screening Test Product Solution and Service
3.7 Date of Enter into Latent Tuberculosis Infection Screening Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection Screening Test Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection Screening Test Historic Market Size by Type (2018-2023)
4.2 Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Type (2024-2029)
5 Latent Tuberculosis Infection Screening Test Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection Screening Test Historic Market Size by Application (2018-2023)
5.2 Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
6.2 North America Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Latent Tuberculosis Infection Screening Test Market Size by Country (2018-2023)
6.4 North America Latent Tuberculosis Infection Screening Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
7.2 Europe Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2018-2023)
7.4 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
8.2 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
9.2 Latin America Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2018-2023)
9.4 Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
10.2 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Detail
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection Screening Test Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.1.5 Qiagen Recent Development
11.2 Oxford Immunotec
11.2.1 Oxford Immunotec Company Detail
11.2.2 Oxford Immunotec Business Overview
11.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Introduction
11.2.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.2.5 Oxford Immunotec Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Introduction
11.3.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Latent Tuberculosis Infection Screening Test Introduction
11.5.4 Sanofi Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Par Sterile
11.6.1 Par Sterile Company Detail
11.6.2 Par Sterile Business Overview
11.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Introduction
11.6.4 Par Sterile Revenue in Latent Tuberculosis Infection Screening Test Business (2018-2023)
11.6.5 Par Sterile Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
